Loading...
6 Metabolic Disorder Drugs Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi, Perrigo Company, CSL Behring, AstraZeneca, Ardelyx
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific
Major Players: Biomarin Pharmaceutical, SOM Innovation Biotech, Homology Medicines, Censa Pharmaceuticals, Codexis
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Heron Therapeutics, Helsinn Healthcare, Teva Pharmaceutical Industries, Novartis, Eisai
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Sanofi, Astellas Pharma, Ardelyx, Alebund Pharmaceuticals, Kyowa Kirin
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: Pfizer, Takeda Pharmaceuticals, Sanofi, BioMarin, Johnson & Johnson
Study Period: 2019 - 2030
Country Covered: United States
Major Players: Merck, AstraZeneca, Pfizer, Novo Nordisk, Sanofi
Filter Reports
By Region
By Countries